TENNOR THERAPEUTICS
TenNor Therapeutics is a clinical stage, product development company with a sharp focus on unmet medical needs in the area of infectious diseases. The company possesses a dual-acting drug discovery platform with several innovative products in various stages of preclinical and clinical development. The company is developing new drugs for the treatment of Helicobacter pylori infections, prosthetic joint infections, multidrug-resistant Gram-negative infections and some other common and serious infectious diseases.
TENNOR THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2013-01-01
Address:
Westfield, New Jersey, United States
Country:
United States
Website Url:
http://www.tennorx.com
Total Employee:
1+
Status:
Active
Contact:
9082330951
Email Addresses:
[email protected]
Total Funding:
76.04 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Content Delivery Network Mobile Non Scaleable Content Nginx GoDaddy DNS PHP DigiCert SSL Encryption Everywhere
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Employees Featured
Founder
Investors List
Broad Resources
Broad Resources investment in Series D - TenNor Therapeutics
Yanchuang Capital
Yanchuang Capital investment in Series D - TenNor Therapeutics
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Series D - TenNor Therapeutics
Zhongnuo Venture Capital
Zhongnuo Venture Capital investment in Series D - TenNor Therapeutics
Besin Capital
Besin Capital investment in Series D - TenNor Therapeutics
Galaxy Capital
Galaxy Capital investment in Series D - TenNor Therapeutics
SNÖ Ventures
SNÖ Ventures investment in Series D - TenNor Therapeutics
Guolian New Venture
Guolian New Venture investment in Series D - TenNor Therapeutics
Oriza Holdings
Oriza Holdings investment in Series D - TenNor Therapeutics
Yanchuang Capital
Yanchuang Capital investment in Series D - TenNor Therapeutics
Official Site Inspections
http://www.tennorx.com Semrush global rank: 11.52 M Semrush visits lastest month: 156
- Host name: 23.91.101.66
- IP address: 23.91.101.66
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
More informations about "TenNor Therapeutics"
丹诺医药 - tennorx.com
TenNor Therapeutics is a clinical-stage company specialized in the discovery and development of “first-in-class” or “best-in-class” new drug products in diseases associated with bacterial infection and metabolism.See details»
TenNor Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 9082330951 TenNor Therapeutics is a clinical stage, product development company with a sharp …See details»
丹诺医药 - tennorx.com
Multiple products entering late-stage of clinical development with indications such as Helicobacter pylori infection, implanted medical device infection, liver cirrhotic hepatic encephalopathy, and …See details»
丹诺医药 - tennorx.com
NEW YORK, NY – TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) drugs, announced today that it …See details»
TenNor Therapeutics Suzhou Ltd.
Www.tennorx.com. Last update 19 Sep 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The statistics for …See details»
TenNor Therapeutics - PharmaBoardroom
Jun 9, 2019 Zhenkun Ma – CEO, TenNor Therapeutics, China. Zhenkun Ma, founder and CEO of TenNor Therapeutics, shares his cross-sectorial experiences in Big Pharma, biotech and …See details»
中国生物制药公司：丹诺医药 TenNor Therapeutics（TennorX）
Nov 21, 2024 丹诺医药有限公司 TenNor Therapeutics Limited（TennorX）创立于2013年，总部位于美国新泽西州Westfield（中国苏州），是一家临床阶段的产品开发公司，专注于传染病领 …See details»
TenNor Therapeutics Suzhou Ltd. (丹诺医药（苏州）有限公司)
了解TenNor Therapeutics Suzhou Ltd. (丹诺医药（苏州）有限公司)公司的药物管线，治疗领域，技术平台，以及它的27项临床试验, 109篇新闻和3篇文献，疾病领域:感染，内分泌与代谢疾 …See details»
TenNor Therapeutics: Contact Details and Business Profile
Tennorx.com; 3 734395XXXX; 734395XXXX; 425373XXXX; Liu Yu CMC Project Manager at TenNor Therapeutics Suzhou, CN View. View Similar People. Related Companies Suzhou …See details»
TenNor Therapeutics | LinkedIn
TenNor Therapeutics Biotechnology Research Suzhou, Jiangsu 91 followers Clinical-stage biotechnology company dedicated to discovery and development of therapeutics in infectious …See details»
Tennor Therapeutics - Overview, News & Similar companies
Jan 17, 2021 Tennor Therapeutics contact info: Phone number: +86 51286861990 Website: www.tennorx.com What does Tennor Therapeutics do? TenNor Therapeutics is a clinical …See details»
丹诺医药 - tennorx.com
SUZHOU, China, Oct. 16, 2024 -- TenNor Therapeutics, a clinical stage company dedicated to developing new therapies to address unmet needs in infectious diseases, announced today …See details»
TenNor - VentureRadar
Acurx Pharmaceuticals, LLC USA n/a Acurx Pharmaceuticals, Inc. is a publicly held, clinical-stage biopharmaceutical company focused on developing a new class of antibiotics targeting …See details»
TenNor Therapeutics - Craft
TenNor Therapeutics has 1 employees at their 1 location. See insights on TenNor Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
TenNor Therapeutics - PitchBook
TenNor Therapeutics General Information Description. Developer of innovative drugs for diseases associated with bacterial infections and bacterial dysbiosis. The company's platform offers a …See details»
丹诺医药 - tennorx.com
专注细菌感染与代谢相关疾病领域. 新药研发的领军企业See details»
【融资】丹诺医药（TennorX）完成超3亿元E轮融资医药新闻-ByDr…
Oct 16, 2024 丹诺医药（TennorX）近日宣布完成逾3亿人民币E轮融资的首批交割。 这轮融资由中山投控旗下中山创投和AMR Action Fund (AMR基金) 共同领投， 所获资金用于支持核心新 …See details»
TenNor Enters Research Collaboration with Janssen for Potential …
SUZHOU, China, Jan. 18, 2021 /PRNewswire/ -- TenNor Therapeutics (Suzhou) Limited, a clinical-stage biopharmaceutical company dedicated to research and development of …See details»
丹诺医药瑞法舒坦唑治疗幽门螺杆菌感染 II 期临床试验取得积极结 …
2022年12月12日，丹诺医药（苏州）有限公司宣布成功完成瑞法舒坦唑（tnp-2198）治疗幽门螺杆菌感染的 ii 期临床试验并取得积极结果。瑞法舒坦唑是专门针对厌氧菌和微需氧菌设计的多靶 …See details»
丹诺医药 - tennorx.com
Antimicrobial agents are the cornerstone of modern medicine, saving countless lives and making many common surgeries possible. However, the problem of antimicrobial resistance is …See details»